Questions of research misconduct follow Trump’s pick for CDC directorBMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k1384 (Published 23 March 2018) Cite this as: BMJ 2018;360:k1384
- Owen Dyer
The virologist Robert Redfield, the Trump administration’s choice to take over the Centers for Disease Control and Prevention, has drawn widespread praise for his clinical work in the areas of HIV and AIDS, hepatitis, and addiction but also criticism for draconian and stigmatising policies that he proposed in the early days of the AIDS epidemic in the US.
Redfield is also dogged by persistent allegations of research misconduct from his time as an army doctor.
Redfield, 66, currently heads clinical care and research at the University of Maryland’s Institute of Human Virology, which he founded with the AIDS pioneer Robert Gallo. He also plays a leading role in clinical programs of PEPFAR (the …